Back to News
Market Impact: 0.18
Bullish Two Hundred Day Moving Average Cross
Source: Nasdaq
Market Technicals & FlowsHealthcare & Biotech
ResMed shares rose about 3.7% Tuesday and crossed above their 200-day moving average of $227.72, reaching an intraday high of $234.33. The technical breakout is a constructive signal for the stock but does not include any new fundamental or earnings information.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.28
Ticker Sentiment
RMD0.42
More News
- ResMed stock jumps 3% on RBC Capital upgrade to Outperform
- Asian markets make nervous start ahead of Fed decision
- Treasury Yields Stay Elevated as Stocks Fall Before Fed
- U.S. stock futures drift higher with Fed rate hike in focus
- The Fed has to walk a fine line Wednesday. How the stock market may react, according to JPMorgan
- US 10-Year Yield Rises to Highest Since 2007 as Fed Looms
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Augmented Intelligence: AllMind, Elevate Human Judgement With an Accessible, Powerful, Data-Driven Financial AI Toolkit
- AI Research Systems for Hedge Funds: A Pilot Design